The new tool could help pinpoint the DNA changes behind hereditary diseases—a crucial step toward genetic medicines.
The data shows that variants predicted to affect microexons are predominant in the 85% of autistic individuals that lack a genetic link.
Colossal Biosciences on October 14, 2026 unveiled GenoMorph, an artificial-intelligence platform developed to identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results